Mukka Proteins Ltd
Incorporated in 2003, Mukka Proteins
Ltd is a manufacturer and exporter
of Fish Meal and Fish oil[1]
- Market Cap ₹ 927 Cr.
- Current Price ₹ 30.9
- High / Low ₹ 56.6 / 28.5
- Stock P/E 20.0
- Book Value ₹ 14.7
- Dividend Yield 0.00 %
- ROCE 11.6 %
- ROE 11.1 %
- Face Value ₹ 1.00
Pros
- Company has delivered good profit growth of 32.6% CAGR over last 5 years
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Debtor days have increased from 52.2 to 72.5 days.
- Working capital days have increased from 163 days to 262 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: FMCG Industry: Food - Processing - Indian
Part of BSE Fast Moving Consumer Goods BSE SmallCap BSE Allcap
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|
409 | 549 | 604 | 770 | 1,177 | 1,380 | 1,006 | |
385 | 525 | 582 | 723 | 1,091 | 1,274 | 912 | |
Operating Profit | 23 | 24 | 22 | 48 | 86 | 105 | 95 |
OPM % | 6% | 4% | 4% | 6% | 7% | 8% | 9% |
2 | 8 | 10 | 7 | 8 | 19 | 16 | |
Interest | 4 | 7 | 8 | 10 | 16 | 25 | 37 |
Depreciation | 2 | 5 | 8 | 9 | 12 | 12 | 14 |
Profit before tax | 19 | 20 | 15 | 36 | 66 | 87 | 60 |
Tax % | 27% | 31% | 29% | 28% | 28% | 15% | 20% |
14 | 14 | 11 | 26 | 48 | 74 | 48 | |
EPS in Rs | 1.10 | 2.00 | 2.34 | 1.55 | |||
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 13% |
3 Years: | 9% |
TTM: | -27% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 33% |
3 Years: | 26% |
TTM: | -33% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | -11% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 20% |
3 Years: | 20% |
Last Year: | 11% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|
Equity Capital | 6 | 6 | 6 | 22 | 22 | 30 | 30 |
Reserves | 38 | 51 | 61 | 76 | 126 | 366 | 411 |
83 | 142 | 159 | 175 | 262 | 365 | 453 | |
74 | 95 | 129 | 119 | 166 | 179 | 183 | |
Total Liabilities | 201 | 293 | 355 | 392 | 575 | 941 | 1,076 |
49 | 78 | 79 | 83 | 85 | 85 | 94 | |
CWIP | 0 | 2 | 4 | 0 | 0 | 0 | 9 |
Investments | 8 | 4 | 12 | 21 | 21 | 31 | 37 |
144 | 209 | 260 | 289 | 469 | 825 | 937 | |
Total Assets | 201 | 293 | 355 | 392 | 575 | 941 | 1,076 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|
-20 | -25 | 2 | 5 | -56 | -150 | -112 | |
-23 | -28 | -14 | -11 | -3 | -51 | -35 | |
34 | 54 | 13 | 15 | 75 | 266 | 56 | |
Net Cash Flow | -9 | 1 | 2 | 8 | 15 | 65 | -91 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|
Debtor Days | 25 | 23 | 29 | 29 | 35 | 49 | 72 |
Inventory Days | 95 | 89 | 106 | 95 | 89 | 136 | 266 |
Days Payable | 63 | 63 | 71 | 56 | 51 | 44 | 67 |
Cash Conversion Cycle | 57 | 49 | 64 | 68 | 73 | 141 | 272 |
Working Capital Days | 63 | 76 | 79 | 77 | 88 | 139 | 262 |
ROCE % | 15% | 9% | 18% | 24% | 19% | 12% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
17 May - Of newspaper publication of audited financial results (standalone and consolidated) for the quarter and year ended 31st March 2025.
-
Announcement Under Regulation 30 Of SEBI LODR Regulations.
15 May - Board approved corporate guarantees of Rs.16.03 Cr for subsidiary and related company credit facilities.
-
Announcement Under Regulation 30 Of SEBI LODR Regulations 2015.
15 May - Appointed M/s. Chethan Nayak & Associates as secretarial auditors for FY 2025-26 to 2029-30.
-
Announcement under Regulation 30 (LODR)-Acquisition
15 May - Mukka Proteins acquires 11% stake in Ocean Proteins for Rs.1.045 Cr, making it a subsidiary.
- Audited Financial Results (Standalone & Consolidated) For The Quarter And Year Ended 31St March 2025. 15 May
Business Overview:[1]
MPL manufactures Fish Protein products and supplies fish meal, fish oil and fish soluble paste
which is an essential ingredient in manufacturing of aqua feed (for fish and shrimp), poultry feed (for broiler and layer) and pet food (dog and cat food). Further, fish oil also finds application in pharmaceutical products (Omega-3 pills and related products derived from fish oil), soap manufacturing, leather tanneries and paint industries